Pharmacodynamics of Echinocandins against Candida glabrata: Requirement for Dosage Escalation To Achieve Maximal Antifungal Activity in Neutropenic Hosts

類似資料

• Pharmacokinetics and Pharmacodynamics of Anidulafungin for Experimental Candida Endophthalmitis: Insights into the Utility of Echinocandins for Treatment of a Potentially Sight-Threatening Infection
  著者:: Livermore, J. L., 等
  出版事項: (2013)
• Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal Therapy
  著者:: Howard, Susan J., 等
  出版事項: (2011)
• Pharmacokinetics and Pharmacodynamics of Fluconazole for Cryptococcal Meningoencephalitis: Implications for Antifungal Therapy and In Vitro Susceptibility Breakpoints
  著者:: Sudan, Ajay, 等
  出版事項: (2013)
• Fks1 and Fks2 Are Functionally Redundant but Differentially Regulated in Candida glabrata: Implications for Echinocandin Resistance
  著者:: Katiyar, Santosh K., 等
  出版事項: (2012)
• Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
  著者:: Kelley R. Healey, 等
  出版事項: (2018-09-01)